➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School
McKesson
Baxter
Moodys

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for Intercept Pharmaceuticals, Inc. v. Optimus Pharma Pvt. Ltd. (D. Del. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. Optimus Pharma Pvt. Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Intercept Pharmaceuticals, Inc. v. Optimus Pharma Pvt. Ltd. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-11-11 13 SO ORDERED Stipulation to Substitute U.S. Patent No. RE48,286 for U.S. Patent No. 7,138,390. Signed by Judge Maryellen…11 September 2020 1:20-cv-01215 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-11-19 17 Complaint - Amended the ’673 patent”); 10,047,117 (filed Nov. 20, 1 The RE286 Patent is a reissue of U.S. Patent No. 7,138,390…or Non-Infringement for U.S. Patent Nos. 7,138,390; 9,238,673; 10,047,117; 10,052,337; and 10,174,073073 patent”); and 10,758,549 (filed Feb. 11, 2020) (“the ’549 patent”) (collectively the “patents-in-… 1. This action for patent infringement, brought pursuant to the patent laws of the United States… expiration of U.S. Patent Nos. RE48,286 (filed June 21, 2019) (“the RE286 patent”);1 9,238,673 (filed External link to document
2020-11-19 18 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s)RE48,286; 9,238,673; 10,047,117; 10,052,…11 September 2020 1:20-cv-01215 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-09-10 4 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,…11 September 2020 1:20-cv-01215 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Boehringer Ingelheim
Dow
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.